Fortis Healthcare Stock Sees -4.3% Decline, Analysts Suggest 'Hold' Amid Underperformance

Fortis Healthcare, a leading player in the healthcare services industry, has seen a decline in its stock price by -4.3% on February 14, 2024. This drop in stock price has been attributed to the company's underperformance in the sector, with a -3.95% difference from the sector's performance on the same day.

According to MarketsMOJO, a leading stock analysis platform, the current stock call for Fortis Healthcare is 'Hold'. This suggests that investors should hold onto their shares and not make any immediate buying or selling decisions.

On the day of the stock's decline, Fortis Healthcare's intraday low was Rs 414.05, which is a -4.83% decrease from its previous closing price. However, the company's stock is still performing well in the long term, with its moving averages higher than the 50-day, 100-day, and 200-day moving averages. It is worth noting that the stock is currently lower than the 5-day and 20-day moving averages.

In comparison to the overall market performance, Fortis Healthcare's stock has underperformed. On the same day, the Sensex, India's benchmark index, had a -0.97% decrease, while Fortis Healthcare's 1-day performance was -3.40%. Similarly, in the past month, the company's stock has seen a -0.25% decrease, while the Sensex has seen a -2.35% decrease.

Overall, Fortis Healthcare's stock has seen a decline in its performance, but it is still performing well in the long term. Investors are advised to hold onto their shares and monitor the company's performance in the coming days.